8 [Cu(TPMA)(Phen)](ClO): Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity.

9 Enhancement of cell internalization and photostability of red and green emitter quantum dots upon entrapment in novel cationic nanoliposomes.

10 Influence of Environmental Conditions on the Fusion of Cationic Liposomes with Living Mammalian Cells.

11 Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.

12 Liposomes-in-Hydrogel Delivery System with Mupirocin: In Vitro Antibiofilm Studies and In Vivo Evaluation in Mice Burn Model

13 Formulation, development and evaluation of bifunctionalized nanoliposomes containing sprout methanolic extract: as effective natural antioxidants on the oxidative stability of soybean oil.

14 Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.

15 Indocyanine green and poly I:C containing thermo-responsive liposomes used in immune-photothermal therapy prevent cancer growth and metastasis.

16 Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.

17 A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy.

18 Optimisation of glutathione conjugation to liposomes quantified with a validated HPLC assay

19 Liposome-based transfection enhances RNAi and CRISPR-mediated mutagenesis in non-model nematode systems

20 Retraction notice to “Carbon dot/TAT peptide co-conjugated bubble nanoliposome for multicolor cell imaging, nuclear-targeted delivery, and chemo/photothermal synergistic therapy” (Chemical Engineering Journal (2017) 312 (144–157)(S1385894716316928)(10.1016/j.cej.2016.11.122)

21 ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

22 Binding of model polycyclic aromatic hydrocarbons and carbamate-pesticides to DNA, BSA, micelles and liposomes

23 Tumor-targeted immuno-liposomes for delivery of therapeutics and diagnostics

24 The stabilization and release performances of curcumin-loaded liposomes coated by high and low molecular weight chitosan

25 Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes.

26 Maltodextrin modified liposomes for drug delivery through the blood-brain barrier.

27 Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes

28 Chemiluminescent liposomes as a theranostic carrier for detection of tumor cells under oxidative stress.

29 A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy

30 Preformulation Study of Electrospun Haemanthamine-Loaded Amphiphilic Nanofibers Intended for a Solid Template for Self-Assembled Liposomes.

31 Supercritical Fluid Technologies to Fabricate Proliposomes.

32 Embedding calix[4]resorcinarenes in liposomes: Experimental and computational investigation of the effect of resorcinarene inclusion on liposome properties and stability.

33 Combined Magnetoliposome Formation and Drug Loading in One Step for Efficient Alternating Current-Magnetic Field Remote-Controlled Drug Release.

34 Effects of Focused-Ultrasound-and-Microbubble-Induced Blood-Brain Barrier Disruption on Drug Transport under Liposome-Mediated Delivery in Brain Tumour: A Pilot Numerical Simulation Study.

35 Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.

36 The preparation of dexamethasone sodium phosphate multivesicular liposomes thermosensative hydrogel and its impact on noise-induced hearing loss in the Guinea pigs

37 Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.

38 Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.

39 State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.

40 Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.

41 Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.

42 Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system.

43 Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.

44 Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery.

45 Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes.

46 Improved Atomic Force Microscopy Stiffness Measurements of Nanoscale Liposomes by Cantilever Tip Shape Evaluation.

47 Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

48 Generation of ironized and multivitamin-loaded liposomes using venturi-based rapid expansion of a supercritical solution (Vent-RESS)

49 antibody-modified liposomes for tumor-targeting delivery of timosaponin aiii

50 liposome-mediated gene transfer into established cns cell lines, primary glial cells, and in vivo

51 cationic nanoliposomes meet mrna: efficient delivery of modified mrna using hemocompatible and stable vectors for therapeutic applications

52 peo-b-ppo star-shaped polymers enhance the structural stability of electrostatically coupled liposome/polyelectrolyte complexes.

53 dual coating of liposomes as encapsulating matrix of antimicrobial peptides: development and characterization

54 influence of liposome forms of rhenium-platinum anti-tumor system on the proliferative activity of cancer cells

55 investigation of fatty acid ketohydrazone modified liposome’s properties as a drug carrier

56 mannosylated liposomes for targeted gene delivery

57 using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy

58 development of curcumin liposome formulations using polyol dilution method

59 specific and cross-reactive immune response against mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from mycobacterium bovis bcg

60 phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry

61 optimization on preparation conditions of salidroside liposome and its immunological activity on pcv-2 in mice

62 local gene delivery system by bubble liposomes and ultrasound exposure into joint synovium

63 transdermal delivery of small interfering rna with elastic cationic liposomes in mice

64 preparation and characterization of baicalein-loaded nanoliposomes for antitumor therapy

65 encapsulation into stealth liposomes enhanced the antitumor action of recombinant cratylia mollis lectin expressed in escherichia coli

66 a novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo

67 liposomes: structure, properties and methods of curative administration in organism

68 improvement of peptide-based tumor immunotherapy using ph-sensitive fusogenic polymer-modified liposomes

69 liposomes as gene delivery vectors for human placental cells

70 liposomes for targeted delivery of active agents against neurodegenerative diseases (alzheimer's disease and parkinson's disease)

71 liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells

72 durable expression of minicircle dna-liposome-delivered androgen receptor cdna in mice with hepatocellular carcinoma

73 liposomes and nanotechnology in drug development: focus on oncotargets

74 cellular injury of cardiomyocytes during hepatocyte growth factor gene transfection with ultrasound-triggered bubble liposome destruction

75 renal-targeted delivery of triptolide by entrapment in pegylated trx-20-modified liposomes

76 hypoxia-responsive ionizable liposome delivery sirna for glioma therapy

77 enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen

78 Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy

79 One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases.

80 Extraction and encapsulation of Laurus nobilis leaf extract with nano-liposome and its effect on oxidative, microbial, bacterial and sensory properties of minced beef

81 Near-infrared light-responsive liposomes for protein delivery: Towards bleeding-free photothermally-assisted thrombolysis.

82 Anticancer activity of Hedyotis corymbosa nanoliposomes targeting estrogen receptor-alpha in breast cancer cells: In silico and in vitro studies

83 Novel Gold-Functionalization of Liposomes and Its Impact on Cellular Uptake and Trafficking.

84 PI3K-AKT-P-gp/Mrp2 signaling pathway drives the accelerated hepatic clearance of encapsulated docetaxel of PEGylated liposomes.

Keyword Connections

Journals

Research Groups

Bibliographies